Search results
Can Pacific Biosciences (PACB) Climb 261% to Reach the Level Wall Street Analysts Expect?
Zacks via Yahoo Finance· 2 years agoThe consensus price target hints at a 261.4% upside potential for Pacific Biosciences (PACB). While...
Unveiling Pacific Biosciences of California (PACB)'s Value: Is It Really Priced Right? A ...
GuruFocus.com via Yahoo Finance· 8 months agoDespite a daily loss of -1.75% and a 3-month loss of -12.74%, Pacific Biosciences of California Inc...
Investors Heavily Search Pacific Biosciences of California, Inc. (PACB): Here is What You Need to...
Zacks via Yahoo Finance· 2 days agoPacific Biosciences of California (PACB) has been one of the most searched-for stocks on Zacks.com...
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
Zacks via Yahoo Finance· 4 months agoPacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its...
Pacific Biosciences (PACB) Upgraded to Buy: Here's What You Should Know
Zacks via Yahoo Finance· 2 weeks agoPacific Biosciences (PACB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism...
Is Pacific Biosciences of California (PACB) Too Good to Be True? A Comprehensive Analysis of a ...
GuruFocus.com via Yahoo Finance· 8 months agoValue-focused investors are always on the hunt for stocks that are priced below their intrinsic...
Pacific Biosciences of California (PACB) Expected to Beat Earnings Estimates: Can the Stock Move...
Zacks via Yahoo Finance· 9 months agoPacific Biosciences (PACB) possesses the right combination of the two key ingredients for a likely...
Pacific Biosciences of California (NASDAQ:PACB) dips 18% this week as increasing losses might not be...
Simply Wall St. via Yahoo Finance· 2 years agoThe art and science of stock market investing requires a tolerance for losing money on some of the...
Investors in Pacific Biosciences of California (NASDAQ:PACB) have unfortunately lost 60% over the...
Simply Wall St. via Yahoo Finance· 5 months agoPacific Biosciences of California, Inc. (NASDAQ:PACB) shareholders should be happy to see the share...
Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) P/S Is On The Mark
Simply Wall St. via Yahoo Finance· 9 months agoPacific Biosciences of California, Inc.'s (NASDAQ:PACB) price-to-sales (or "P/S") ratio of 19.7x...